期刊文献+

VCP蛋白表达与胃癌预后的相关性研究

Association of expression of valosin containing protein with prognosis of gastric carcinoma
下载PDF
导出
摘要 目的:探讨VCP蛋白表达与胃癌预后的关系,确立VCP作为判断胃癌预后的独立因子作用。方法:在187例胃癌组织手术标本中进行VCP的免疫组织化学染色,比较肿瘤细胞和正常血管内皮细胞VCP的表达,并结合肿瘤浸润、转移、预后等临床因素进行分析比较。结果:VCP的表达与胃癌的浸润、淋巴结转移相关,单变量分析中年龄、胃癌的浸润深度、脉管浸润、淋巴结转移及远处转移等因素显示与胃癌的预后相关(P<0.05),多变量分析显示了VCP表达水平较肿瘤的分化、淋巴结浸润、转移与胃癌预后相关的危险系数高,故VCP的表达更能反映胃癌的预后。结论:VCP的表达是胃癌重要、独立的预后因子。 Objective:To examine the association of expression of valosin containing protein (VCP) with the prognosis of gastric carcinoma (GC) and to investigate whether VCP was an independent risk factor for GC. Methods: VCP expression in 187 GC specimens was analyzed by immunohistochemistry and compared between tumor cells and normal endothelial cells. Association between VCP expression and clinieopathologic factors of GC patients was analyzed. Results: High VCP expression was associated with deep tumor invasion and lymph node metastasis (P〈0.005). Univariate analysis showed that age, invasion depth, vascular invasion, lymph node metastasis, and distal metastasis were related with prognosis of GC (P〈0. 05). Multivariate analysis revealed that the level of VCP expression was a higher risk coefficient than tumor differentiation, lymph node invasion and metastasis for prognosis of GC. So VCP was an independent predictor for disease-free and overall survival. Conclusion:VCP expression is an independent risk factor for GC.
出处 《肿瘤》 CAS CSCD 北大核心 2006年第10期935-940,共6页 Tumor
关键词 胃肿瘤 肿瘤浸润 肿瘤转移 预后 VCP(Valosln- CONTAINING Protein) Stomach neoplasms Neoplasm infiltration Neoplasm metastasis Prognosis VCP(valosin-containing protein)
  • 相关文献

参考文献2

二级参考文献18

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:226
  • 2Rapheal E Pollock 孙燕等(译).国际抗癌联盟临床肿瘤学手册(第7版)[M].吉林:吉林科学技术出版社,2001.141-179. 被引量:1
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Matsushita M, Hajiro K, Suzaki T, et al. Histopathological assessment of lymph node metastasis in patients with gastric cancer. Hepatogastroenterology,1995,42:861-866. 被引量:1
  • 5Sasaki M, Watanabe H, Jass JR, et al. Occult lymph node metastasis detected by cytokeratin immunohistochemistry predict recurrence in "node negative" colorectal cancer. J Gastroenterol, 1997, 32:758-764. 被引量:1
  • 6Sedmak DD, Meineke TA, Knechtges DS, et al. Detection of metastatic breast carcinoma with monoclonal antibodies to cytokeratins. Arch Pathol Lab Med, 1989, 113:786-789. 被引量:1
  • 7Cai J, Ikeguchi M, Maeta M, et al. Clinicopathological value of immunohistochemical detection of occult involvement in pT3N0 gastric cancer. Gastric Cancer, 1999,2:95-100. 被引量:1
  • 8Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-second English edition. Gastric Cancer, 1998, 1:10-24. 被引量:1
  • 9Natsugoe S, Aikou T, Shimada M, et al. Occult lymph node metastasis in gastric cancer with submucosal invasion. Jpn J Surg, 1994,24:870-875. 被引量:1
  • 10Noguchi S, Hiratsuka M, Furukawa H, et al. Detection of gastric cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res, 1996, 87:650-654. 被引量:1

共引文献177

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部